Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Dermavant’s Vtama Appears Well Positioned To Compete With Other Topicals In AD
Mar 15 2023
•
By
Joseph Haas
Dermavant is working toward adding atopic dermatitis to Vtama's label • Source: Shutterstock
Keep up with the top pharma business news of the week. On the go.
Scrip brings you a weekly bulletin of top picks.
More from Strategy
More from Business